NCT05527847Completed
Peers EXCEL Trial to Improve Glycemic Control
A Pilot Randomized Clinical Trial (RCT) to Examine the Benefits of a Culturally Adapted Peer Support and Self-Management Intervention to Improve Glycemic Control in African Americans
Source: ClinicalTrials.gov · Last updated 18 Nov 2023
Brief summary (registry, in English)
The purpose of the study is to gather input about the value of adding a newly developed diabetes self-management program to an existing diabetes self-management program. Participants will self-identify as African-American/Black with type 2 diabetes, and prescribed a diabetes medication. Participants can expect to be in the study for 6 months.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 14 (actual)
- First submitted
- 1 Sept 2022
- Start date
- 13 Feb 2023
- Primary completion date
- 2 Oct 2023
- Lead sponsor
- University of Wisconsin, Madison
- Diseases
- Type 2 diabetes
- NCT number
- NCT05527847
What you commit to
- Study type: Interventional
- Participants enrolled: 14
- From 13 Feb 2023 to the primary completion date, 2 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participating in another lifestyle or medication adherence program
Other illness
- Self-reported bipolar or personality disorders, schizophrenia, Alcohol and Other Drug Abuse (AODA), dementia
- Older adults who have a history of severe hypoglycemia requiring medical assistance or glucagon administration
Who the study is looking for
- Between 18-90 years old
- Self-identify as African-American
- Diagnosis of Type 2 diabetes
- Able to speak/read English
- Self-report having a primary care provider who prescribes one diabetes medication
- Diagnosed with diabetes for ≥1 year at point of care
- Will reside in the geographical area throughout the study period
- Self-reported nonadherence on the DOSE-nonadherence survey
- ≥7.5% A1C
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Wisconsin Coordinator of this site? Confirm its status | Madison | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.